Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4685 USD | -2.15% | -8.14% | -55.39% |
Mar. 21 | Evoke Pharma, Inc. Announces Board Changes as of March 31, 2024 | CI |
Mar. 21 | Evoke Pharma, Inc. Announces Chief Executive Officer Changes as of March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 14.08M | Sales 2025 * | 21.9M | Capitalization | 3.97M |
---|---|---|---|---|---|
Net income 2024 * | -3M | Net income 2025 * | 1M | EV / Sales 2024 * | 0.28 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.18 x |
P/E ratio 2024 * |
-2.04
x | P/E ratio 2025 * |
15.6
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.62% |
Latest transcript on Evoke Pharma, Inc.
1 day | -2.15% | ||
1 week | -8.14% | ||
Current month | -23.20% | ||
1 month | -23.07% | ||
3 months | -39.16% | ||
6 months | -63.40% | ||
Current year | -55.39% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 06-12-31 | |
Marilyn Carlson
CTO | Chief Tech/Sci/R&D Officer | 76 | 13-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cam L. Garner
FOU | Founder | 75 | 06-12-31 |
Kenneth Widder
BRD | Director/Board Member | 71 | 07-05-31 |
Todd Brady
BRD | Director/Board Member | 52 | 07-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 0.4685 | -2.15% | 1,943 |
24-04-18 | 0.4788 | -12.79% | 21,941 |
24-04-17 | 0.549 | +16.81% | 20,068 |
24-04-16 | 0.47 | -1.09% | 25,436 |
24-04-15 | 0.4752 | -6.82% | 26,133 |
Delayed Quote Nasdaq, April 19, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.39% | 3.97M | |
+24.60% | 654B | |
+24.08% | 552B | |
-5.63% | 356B | |
+15.37% | 319B | |
+7.38% | 295B | |
+3.26% | 211B | |
+0.78% | 206B | |
-9.69% | 147B | |
-6.63% | 144B |
- Stock Market
- Equities
- EVOK Stock